文献速递眼底病与葡萄膜炎

从中期到晚期年龄相关性黄斑变性的进展速率与CFH基因座风险等位基因数量相关

Progression Rate From Intermediate to Advanced Age-Related Macular Degeneration Is Correlated With the Number of Risk Alleles at the CFH Locus.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2016-01-01

研究探讨中期年龄相关性黄斑变性(AMD)向地图样萎缩(GA)或脉络膜新生血管(CNV)的进展速率是否与四个强关联基因的七个单核苷酸多态性(SNP)基因型相关。Cox比例风险模型显示,CFH:rs10737680风险等位基因数量与进展速率相关,携带两个风险等位基因者较一个者进展更快(HR=1.61,95%CI=1.08-2.40,P<0.02,n=547眼),但Bonferroni校正后不显著。结论支持CFH影响AMD进展速率,但该SNP仅解释年龄之外较小部分变异,建议其他因素参与进展。

要点

  • CFH:rs10737680风险等位基因数量与中期AMD进展速率相关,两个风险等位基因者较一个者进展更快(HR=1.61,95%CI=1.08-2.40,P<0.02,n=547眼)。
  • 该关联在Bonferroni校正后不显著,且CFH:rs10737680仅解释年龄之外较小部分进展速率变异。
  • CFH:rs10737680对向CNV进展的影响强于向GA进展;CFH:rs1061170(Y402H)与进展速率无关。

核心结论

  • 结果支持既往发现,即AMD进展速率受CFH影响,并提示CFH内变异对风险与进展可能有不同效应。
  • 由于CFH:rs10737680在Bonferroni校正后不显著且仅解释年龄之外较小部分进展速率变异,作者认为其他因素参与进展。

研究设计与样本

  • 研究纳入中期AMD眼,检测与晚期AMD风险最强关联的四个基因中的七个SNP基因型,分析进展至GA或CNV的时间与基因型的关联。
  • 采用Cox比例风险生存模型,调整年龄和性别,并考虑可变随访时间、右删失数据和重复测量(左右眼)。

主要发现

  • 进展速率随CFH:rs10737680风险等位基因数量变化,但与CFH:rs1061170(Y402H)SNP无关。
  • 携带两个风险等位基因者较携带一个者进展更快(HR=1.61,95%CI=1.08-2.40,P<0.02,n=547眼),但Bonferroni校正后不显著。
  • 该信号可能由相关的保护性变异CFH:rs6677604驱动,该变异标记CFHR1-3缺失;携带至少一个保护等位基因者进展更慢。
  • 分别分析GA和CNV显示,CFH:rs10737680对向CNV进展的效应更强。

局限性

  • CFH:rs10737680在Bonferroni校正后不显著。
  • CFH:rs10737680仅解释年龄之外相对较小部分进展速率变异,作者建议其他因素参与进展。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Progression rate of age-related macular degeneration (AMD) varies substantially, yet its association with genetic variation has not been widely examined. METHODS: We tested whether progression rate from intermediate AMD to geographic atrophy (GA) or choroidal neovascularization (CNV) was correlated with genotype at seven single nucleotide polymorphisms (SNPs) in the four genes most strongly associated with risk of advanced AMD. Cox proportional hazards survival models examined the association between progression time and SNP genotype while adjusting for age and sex and accounting for variable follow-up time, right censored data, and repeated measures (left and right eyes). RESULTS: Progression rate varied with the number of risk alleles at the CFH:rs10737680 but not the CFH:rs1061170 (Y402H) SNP; individuals with two risk alleles progressed faster than those with one allele (hazard ratio [HR] = 1.61, 95% confidence interval [CI] = 1.08-2.40, P < 0.02, n = 547 eyes), although this was not significant after Bonferroni correction. This signal was likely driven by an association at the correlated protective variant, CFH:rs6677604, which tags the CFHR1-3 deletion; individuals with at least one protective allele progressed more slowly. Considering GA and CNV separately showed that the effect of CFH:rs10737680 was stronger for progression to CNV. CONCLUSIONS: Results support previous findings that AMD progression rate is influenced by CFH, and suggest that variants within CFH may have different effects on risk versus progression. However, since CFH:rs10737680 was not significant after Bonferroni correction and explained only a relatively small portion of variation in progression rate beyond that explained by age, we suggest that additional factors contribute to progression.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Sardell RJ, Persad PJ, Pan SS, et al. Progression Rate From Intermediate to Advanced Age-Related Macular Degeneration Is Correlated With the Number of Risk Alleles at the CFH Locus. Invest Ophthalmol Vis Sci. 2016. PMID: 27832277. doi:10.1167/iovs.16-19519

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。